| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.39B | +13.3% |
| Cost of Revenue | $1.56B | +8.3% |
| Gross Profit | $830.0M | +23.9% |
| R&D Expense | $55.0M | +10.0% |
| SG&A Expense | $393.0M | +9.8% |
| Operating Income | $333.0M | +84.0% |
| Interest Expense | $4.0M | -80.0% |
| Pre-tax Income | $206.0M | +52.6% |
| Income Tax | $25.0M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $646.0M | +207.6% |
| Accounts Receivable | $402.0M | +8.9% |
| Inventory | $629.0M | +33.0% |
| Current Assets | $1.77B | +3.0% |
| Total Assets | $6.21B | -6.0% |
| Current Liabilities | $553.0M | -40.8% |
| Long-term Debt | $1.27B | -20.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Capital Expenditures | $113.0M | +7.6% |
| Financing Cash Flow | -$896.0M | -110.3% |
| +165.8% |
| Net Income | $927.0M | +321.4% |
| EPS (Basic) | $16.71 | +360.3% |
| EPS (Diluted) | $16.41 | +357.1% |
| Stockholders' Equity |
| $3.22B |
| +17.0% |